AI Wearable EPISERAS Predicts Seizures in Real Time
Neuraxpharm and mjn-neuro will launch EPISERAS, an AI-based earpiece that predicts seizures minutes in advance, offering real-time alerts for patients with drug-resistant epilepsy.
Neurology
NeuroPulse Daily: Next-Gen AI Imaging Debuts, ALS Trial Readiness Builds, and CMS Boosts Neurostimulation Payments
AI Imaging Advances, ALS Pipeline Progress, and New CMS Reimbursement Gains Signal Steady Momentum in a Holiday-Quiet Neurology Cycle Even as Thanksgiving week typically slows the flow of biotech and medtech announcements, the neurology sector delivered a trio of meaningful developments across imaging innovation, neurodegenerative drug progress, and federal reimbursement policy. Together, they reflect a … Read more
NeuroPulse Daily: Reimbursement Shifts, ALS/SMA Trial Momentum, and Next-Gen Imaging & Robotic Spine Innovations
This edition of Synopulse’s NeuroPulse tracks major CMS reimbursement boosts, pivotal ALS and SMA milestones, robotic and AI-powered medtech breakthroughs, and new biomarker and neurodevelopment updates shaping tomorrow’s neurology landscape.
NeuroPulse Daily: CMS Stability, PrimeC Phase 3 Approval, and Next-Gen CT Imaging Momentum
Today’s Synopulse NeuroPulse Daily Summary highlights major shifts in neurology, from CMS reimbursement stability and pivotal trial clearances to new medtech platforms and key financing rounds, capturing the most critical regulatory, clinical, and innovation-driven movements shaping the field.
NeuroPulse Daily – ASPN PNS Guideline Headlines a Busy Day of Deals, Diagnostics, and Neurotechnology Progress
Synopulse’s NeuroPulse Daily tracks major movements across neurology, including new Parkinson’s diagnostics, ALS care funding, Huntington’s genetic medicine progress, AI-powered imaging clearance, breakthrough neurotechnology, and multimillion-dollar collaborations accelerating CNS drug discovery.
Bain Capital Acquires Mitsubishi Tanabe Pharma
Bain Capital, a leading global private investment firm with approximately $160 billion in assets under management, has announced its agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC), a renowned Japanese pharmaceutical company with over 300 years of heritage. This transaction represents one of Bain Capital’s largest investments in the pharmaceutical sector and demonstrates its continued … Read more